Is the FDA capable of regulating hemp CBD? – podcast

The U.S. Food and Drug Administration is set up to assess and approve single synthetic chemical constituent pharmaceutical drugs—drug, after all, is its middle name. But food is its first name, yet the agency has a great deal of difficulty regulating dietary supplements, in particular botanicals with many different active phytochemicals in a plant, and especially hemp CBD with one ingredient in particular, THC, being a controlled substance drug! So it’s a challenging scenario all the way around, from the regulators to the would-be regulated. Natural Products Insider senior editor Todd Runestad digs into these important—and vexing—issues with Duffy MacKay, senior vice president of scientific and regulatory affairs for CV Sciences, a pioneering and leading brand known for its PlusCBD Oil line. Tune in and listen to the pair discuss some provocative issues, including: What does regulatory compliance look like to a hemp CBD company? What else looks different in the hemp CBD world compared to the larger dietary supplements business? Crystal ball question: What do ultimate hemp CBD regulations might look like? Pharma only? Food allowed? Upper safe limits established? No isolate? MacKay will be leading a discussion with many of the hemp CBD industry’s leading legal minds, in a webinar, “Legal, regulatory and market forces shaping the hemp CBD industry,” Thursday, July 2, from 2-3pm Eastern time, 11-12 Pacific. To register, go to naturalproductsinsider.com and atop the home page, on that bar, click on Media Assets, then Webinars, and scroll down till you see the title, and register.